Tuesday, October 13, 2009
Glaxo Ordered to Pay $2.5 Million for Paxil Defects
THEY FAILED TO WARN PREGNANT MOTHERS ABOUT PAXIL'S DANGERS.
UTTERLY DESPICABLE ACT!
Just in from Bloomberg!
GlaxoSmithKline Plc must pay $2.5 million over claims that its Paxil antidepressant caused birth defects, a Pennsylvania jury concluded in the first of 600 such cases to come to trial.
Jurors in state court in Philadelphia deliberated about seven hours over two days before finding Glaxo failed to properly warn doctors and pregnant users of Paxil’s risk. The panel awarded $2.5 million in compensatory damages to the family of Lyam Kilker. The 3-year-old was born with heart defects his mother blamed on the drug.
“The first win is always huge, especially when you get a jury saying the drug caused the injury,” Sean Tracey, the family’s lawyer, said in an interview after the verdict.
It’s the first time a jury has considered claims that Glaxo, the U.K.’s largest drugmaker, knew Paxil caused birth defects and hid the risk to increase profits. The drug, approved for U.S. use in 1992, generated about $942 million in sales last year, or 2.1 percent of Glaxo’s total revenue.
The company disagrees with the verdict and will appeal, Kevin Colgan, a spokesman, said in an e-mailed statement.
“While we sympathize with Lyam Kilker and his family, the scientific evidence does not establish that exposure to Paxil during pregnancy caused his condition,” Colgan said.
Glaxo’s provision for legal and other nontax disputes as of June 30 was 1.7 billion pounds ($2.8 billion), it said in a July 22 regulatory filing that didn’t mention the Paxil litigation.
Heart Defects’ Cause
In the Kilker case, jurors found 10-2 that Glaxo officials “negligently failed to warn” the doctor treating Lyam’s mother about Paxil’s risks and concluded the medicine was a “factual cause” of the child’s heart defects.
The Philadelphia Common Pleas Court panel also found that Glaxo’s handling of the drug wasn’t “outrageous,” meaning the family couldn’t seek punitive damages against the drugmaker.
Glaxo is also fighting suits in the U.S., Canada and the U.K. over claims that Paxil, whose generic name is paroxetine, causes homicidal and suicidal behavior. The company settled some suicide claims, under undisclosed terms.
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
About the Author :
Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
Labels: BOB FIDDAMAN, Fiddaman, KILKER V GLAXOSMITHKLINE, Paxil, Seroxat Sufferers Stand Up and be Counted